Novo Nordisk A/S Sponsored ADR (NVO)
Market Closed
17 Jul, 20:00
$
50. 32
-1.16
-2.2533%
$
219.88B Market Cap
48.26 P/E Ratio
0.32% Div Yield
9.54M Volume
0 Eps
$ 51.48
Previous Close Want to track NVO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Novo Nordisk A/S Sponsored ADR (NVO) Statistics
Valuation metrics
Market Cap 219.88B
Enterprise value 1.59T
Trailing P/E (ttm) 12.02
Forward P/E 11.21
PEG ratio 0.72
Price/Sales (ttm) 4.47
Price/Book (mrq) 7.22
Enterprise Value/Revenue 4.85
Enterprise Value/EBITDA 8.94
Overview
Shares outstanding 4.44B
Float 3.19B
Shares short 19.93M
% Held by insiders 0%
% Held by institutions 0.09%
Average volume (10 days) 8.35M
Average volume (90 days) 14.37M
Price summary
52-Week low 35.12
52-Week high 71.8
Beta 0.27
50-Day moving average 47.7
200-Day moving average 45.73
Dividends and splits
Forward annual dividend rate 2.55
Forward annual dividend yield 0.0619%
Trailing annual dividend rate 11.7
Trailing annual dividend yield 0.0355%
5-Year annual dividend yield 1.72%
Payout ratio 0.42
Dividend Date 8 Apr 2026
Ex-Dividend Date 30 Mar 2026
Last split factor 2:1
Last split Date 20 Sep 2023
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.37%
Operating margin 0.45%
Operational effectiveness
Return on assets 0.22%
Return on equity 0.66%
Income Statement
Revenue (ttm) 48.34B
Revenue per share (ttm) 73.79
Quarterly revenue growth (yoy) -0.08%
Gross profit (ttm) 39.84B
EBITDA 158.38B
Net income to common (ttm) 16.02B
Diluted EPS (ttm) 27.45
Quarterly earnings growth (yoy) -0.05%
Balance Sheet
Total cash (mrq) 4.22B
Total cash per share (mrq) 4.87
Total debt (mrq) 20.48B
Total Debt/Equity (mrq) 0.72
Current ratio (mrq) 0.79%
Book value per share (mrq) 45.71
Cash Flow
Cash flow statement 18.63B
Levered free cash flow (LFCF) 58.95M
